Related Experiment Video
Updated: Sep 27, 2025

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
Managing Type 1 Diabetes from Gynecological Waste: Trash to Treasure
Rohit G Kumbhar1, Shivani Desai1, Ramesh R Bhonde2
1Department of Pharmacology, Dr. D.Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune, India.
Human umbilical cord blood (hUCB) cells show promise for managing type 1 diabetes mellitus (T1DM). Their regenerative and immunological properties offer a potential therapeutic avenue for this autoimmune disease.
Area of Science:
- Immunology
- Endocrinology
- Regenerative Medicine
Background:
- Type 1 diabetes mellitus (T1DM) is an autoimmune condition characterized by the destruction of pancreatic beta cells, leading to impaired glucose homeostasis.
- Human umbilical cord blood (hUCB) cells offer potential advantages over other stem cell sources, including lower risk of viral contamination, non-invasive harvesting, and reduced immunogenicity.
- hUCB cells possess inherent regenerative capabilities and immunomodulatory properties, making them attractive for therapeutic applications.
Purpose of the Study:
- To explore the potential of human umbilical cord blood (hUCB) cells as a therapeutic strategy for managing type 1 diabetes mellitus (T1DM).
- To highlight the unique advantages of hUCB cells, including their safety profile, ease of access, and regenerative potential in the context of T1DM treatment.
Main Methods:
- Review of preclinical data on the safety and efficacy of autologous cord blood cell infusion.
- Analysis of the biological characteristics of hUCB cells, including their differentiation potential and immunogenicity.
- Evaluation of the regenerative capabilities and immunological properties of stem cells for T1DM management.
Main Results:
- Preclinical data suggest that autologous cord blood cell infusion is safe due to their non-antigenic nature.
- hUCB cells demonstrate significant potential for regeneration and differentiation into various cell types.
- The regenerative and immunological characteristics of stem cells, particularly hUCB cells, show promise for T1DM management.
Conclusions:
- Human umbilical cord blood (hUCB) cells represent a valuable resource for T1DM management due to their regenerative potential and favorable immunological profile.
- The ease of isolation and reduced ethical concerns associated with hUCB cells make them a practical and promising medical intervention for T1DM.
- Further research into hUCB cell-based therapies could lead to novel treatment strategies for type 1 diabetes mellitus.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

